HomenewsEconomicsFDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

  • June 2, 2023
  • Posted by: GMI-Co
  • Category: Economics
No Comments

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.



Leave a Reply